Febuxostat Versus Allopurinol Use in Gout Patients: A Real-World Study

While the febuxostat group showed more events, this was associated with a higher prevalence of almost all risk factors. Interpreting study results and applying them practically remain difficult given the constellation's commonality in clinical life; therefore, careful consideration is necessary.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-10-27
DOI
https://doi.org/10.7759/cureus.95499
Primary Topic
Gout, Hyperuricemia, Uric Acid
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Febuxostat Versus Allopurinol Use in Gout Patients: A Real-World Study

Anne-Kathrin Tausche, Josephin Voskamp
Cureus
Gout, Hyperuricemia, Uric Acid
article

Febuxostat Versus Allopurinol Use in Gout Patients: A Real-World Study

Anne-Kathrin Tausche, Josephin Voskamp
article en

Abstract

While the febuxostat group showed more events, this was associated with a higher prevalence of almost all risk factors. Interpreting study results and applying them practically remain difficult given the constellation's commonality in clinical life; therefore, careful consideration is necessary.

CureusVol. 17(10)
Technische Universität Dresden (DE)
Openalex Percentile: Top 64%
Gout, Hyperuricemia, Uric Acid
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Febuxostat Versus Allopurinol Use in Gout Patients: A Real-World Study — Anne-Kathrin Tausche, Josephin Voskamp · Cureus (2025) | TGRS Research Map | TGRS